Literature DB >> 5782118

Antitumour activity in a series of bisdiketopiperazines.

A M Creighton, K Hellmann, S Whitecross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5782118     DOI： 10.1038/222384a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  29 in total

1.  Combined razoxane and radiotherapy for melanoma brain metastases. a retrospective analysis.

Authors:  Walter Rhomberg; Helmut Eiter; Franz Boehler; Christoph Saely; Robert Strohal
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

2.  Effect of ICRF 159 on immune responses.

Authors:  K Hellmann
Journal:  Proc R Soc Med       Date:  1972-03

3.  The effect of bisdioxopiperazines on the synthesis of deoxyribonucleic acid, ribonucleic acid and protein in growing mouse-embryo fibroblasts.

Authors:  A M Creighton; G D Birnie
Journal:  Biochem J       Date:  1969-10       Impact factor: 3.857

4.  Drug-induced inhibition of tumour cell dissemination.

Authors:  K Burrage; K Hellmann; A J Salsbury
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

5.  Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristic.

Authors:  A J Salsbury; K Burrage; K Hellmann
Journal:  Br Med J       Date:  1970-11-07

6.  Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's sarcoma (AIDS-KS).

Authors:  A Chachoua; M Green; J Wernz; F Muggia
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

7.  Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.

Authors:  T Narita; S Yaguchi; T Komatsu; M Takase; A Hoshino; M Inaba; S Tsukagoshi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Reduction of chronic doxorubicin cardiotoxicity in beagle dogs by bis-morpholinomethyl derivative of razoxane (ICRF-159).

Authors:  E H Herman; V J Ferrans; H B Bhat; D T Witiak
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Antimetastatic effects of razoxane in a rat osteosarcoma model.

Authors:  F Wingen; H Spring; D Schmähl
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

10.  Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane.

Authors:  S L Maloney; D C Sullivan; S Suchting; J M J Herbert; E M Rabai; Z Nagy; J Barker; S Sundar; R Bicknell
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.